Table 3.
Differences in time to admission, mean stay, treatments received, and complications
| Variable | Overall | Survivors | Dead | |
|---|---|---|---|---|
| (n = 163) | (n = 93) | (n = 70) | p | |
| Time symptoms to admission (mean, days [SD]) | 5.73 (5.95) | 6.32 (6.46) | 4.89 (5.07) | 0.138 |
| Mean stay (mean, days [SD]) | 9.45 (7.12) | 12.08 (7.56) | 6.04 (4.69) | <0.001 |
| Treatments (n, %) | ||||
| Antibiotics | 149 (90.9) | 87 (92.6) | 62 (88.6) | 0.382 |
| Chloroquine | 33 (20.2) | 18 (19.4) | 15 (21.4%) | 0.744 |
| Hydroxychloroquine | 124 (75.6) | 77 (81.9) | 47 (67.1) | 0.029 |
| Lopinavir/ritonavir | 127 (77.4) | 72 (76.6) | 55 (78.6) | 0.765 |
| Interferon | 4 (2.4) | 2 (2.1) | 2 (2.9) | 0.765 |
| Corticosteroids | 86 (52.4) | 39 (41.5) | 47 (67.1) | 0.001 |
| Total dose (mg PDN, [SD]) | 508.91 (708.53) | 475.78 (773.72) | 553.4 (612.8) | 0.489 |
| Mean dose (mg PDN, [SD]) | 172.96 (112.17) | 118.31 (63.92) | 217.36 (123.4) | <0.001 |
| Tocilizumab | 11 (6.7) | 10 (10.8) | 1 (1.4) | 0.025 |
| Heparin | 56 (34.4) | 38 (40.9) | 18 (25.7) | 0.044 |
| Complications | ||||
| Bacterial infection | 14 (8.5) | 8 (8.5) | 6 (8.6) | 0.989 |
| Kidney injury | 36 (22) | 16 (17) | 20 (28.6) | 0.077 |
| Liver injury | 5 (3) | 1 (1.1) | 4 (5.7) | 0.087 |
| Heart failure | 20 (12.2) | 8 (8.5) | 12 (17.1) | 0.095 |
| Thrombosis | 4 (2.4) | 4 (4.3) | 0 | 0.137 |
| Bleeding | 4 (2.4) | 1 (1.1) | 3 (4.3) | 0.314 |
| Confusional syndrome | 24 (14.6) | 12 (12.8) | 12 (17.1) | 0.433 |
| Transfusion | 7 (4.3) | 6 (6.4) | 1 (1.4) | 0.240 |
Note: p‐values represent the comparison between survivors and dead groups.
Abbreviations: PDN, prednisone; SD, standard deviation.